NAF This Week podcast

NAF This Week - Episode 6 - October 22, 2026

10/22/2026
0:00
9:38
Rewind 15 seconds
Fast Forward 15 seconds

Welcome to Episode #6 of NAF This Week! 

Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community — from research and advocacy to programs, events, and more. 

In this episode:  This week, Andrew discusses recent FDA developments and what a new rare disease framework could mean for the Ataxia community. He highlights the importance of patient engagement, outside expertise, and a more predictable drug development process, along with opportunities for the community to learn more and get involved.

Links & Resources Mentioned: 

🔗 Rare Disease Framework Public Meeting – October 28: www.reaganudall.org/news-and-events/events/rare-disease-framework-public-meeting

🔗 FDA White Paper – A New Framework for Rare Disease Review: www.fda.gov/media/195694/download?attachment

🔗 Information about SARA Scores: www.ataxia.org/scasourceposts/snapshot-what-is-the-f-sara

 

Stay Connected with NAF:  Visit www.ataxia.org to learn more about Ataxia, find resources and support, get involved, and follow the latest progress in Ataxia research. 

More episodes from "NAF This Week"